Genedrive plc
Company Profile
Company website
Sector
Pharmaceuticals and Biotechnology (Biotechnology)
Description
Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications.
The Company has assays on the market for the detection of MT-RNR1, HCV, certain military biological targets, a high throughput SARS-CoV-2 assay and a point of care test for Covid-19.
The company are currently developing a genetic test for CYP2C19 metaboliser status.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Latest Company Summary
Investor Access
30
Dec
Event information
Management will hold the company’s AGM on Monday, 30 December 2024
The Company’s 2024 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.phpVenue
At 46 Grafton Street, Manchester M13 9XX
Time
Monday, 30 December 2024 at 10am
Financial Calendar
| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results | November |
| Interim Results* | March |
| AGM* | December |
* Months based on previous announcements of this kind
